With the rising demand for weight-loss medications, compounding pharmacies have been making headlines lately. On October 30, ...

Viking Therapeutics Inc.’s stock rose 2% Friday as excitement continued to build about data on its oral weight-loss drug the ...

A significant update in these guidelines includes considering GLP-1 drugs, such as Wegovy and Ozempic, for patients with ...

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

On Friday, Novo Nordisk A/S (NYSE:NVO) released headline results from part 1 of the ongoing ESSENCE Phase 3 trial, a 240-week ...

A new Northbrook pharma will work to bring its obesity treatment to market that it says holds advantages over Ozempic and its ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

GSK acquired an experimental therapy from Chimagen Biosciences, paying $300 million upfront for the “T-cell engager” therapy, ...

Eli Lilly and its investors this past week learned a hard lesson: The sky is no longer the limit when it comes to sales of its blockbuster glucagon-like peptide 1 (GLP-1) drugs for diabetes and ...

A nuclear power company has outperformed every stock in the S&P 500 so far this year. Nov 1, 2024 by Adam Spatacco The Future of Defense Is Artificial Intelligence (AI). Here's Why Palantir Is My Top ...